778-990-2482

We help you achieve your goal.

Efficient clinical trial recruitment starts with how you engage patients.

Antiquated recruitment methodologies drive up recruitment costs and drive down enrollment rates, unnecessarily. With over 180 million Americans willing to participate in research, no trial should ever fail to meet enrollment goals.

MedAnswers is the transformational health-technology company combining high-tech with high-touch solutions that converge clinical research with clinical care. We reach highly-engaged, diverse patient populations both outside and inside your clinical trial sites, turning engaged patient communities into long-term assets, at a fraction of industry average costs.

Partners

Whether you’re a newbie landing page creator or a pro, Unbounce gives you the tools to not only build custom landing pages, but also get more conversions on your website.

Thank you! Your form has been successfully submitted.

Thank you! Your form has been successfully submitted.

Thank you! Your form has been successfully submitted.

Lorem ipsum dolor sit amet, consectetur adipiscing.

Lorem ipsum dolor sit amet, consectetur adipiscing.

Lorem ipsum dolor sit amet, consectetur adipiscing.

Patient Engagement

25%

From Phase 1 through Market Access, we build long-term, highly engaged audiences for you to recruit from now and later.

Data set

100% Enrollment

25%

We co-create patient-centric studies, and use modern, patient-consented identification techniques including genomics and other lab data.

Data set

Participant Diversity

25%

Trust begins with transparency and generosity: We meet patients where they are and ensure they get their questions answered safely and anonymously.

Data set

Feature

25%

Et has minim elitr intellegat. Mea aeterno eleifend antiopam ad, nam no suscipit quaerendum.

Data set

Feature

25%

Et has minim elitr intellegat. Mea aeterno eleifend antiopam ad, nam no suscipit quaerendum.

Data set

Feature

25%

Et has minim elitr intellegat. Mea aeterno eleifend antiopam ad, nam no suscipit quaerendum.

Data set

Feature

25%

Et has minim elitr intellegat. Mea aeterno eleifend antiopam ad, nam no suscipit quaerendum.

Data set

Feature

25%

Et has minim elitr intellegat. Mea aeterno eleifend antiopam ad, nam no suscipit quaerendum.

Data set

Modern Approach. Deeply personal.

The seed for MedAnswers was planted seven years before it sprouted when founder, Alice Crisci, was faced with entering a three-year clinical trial to treat a breast cancer diagnosis when she was a young adult.

As Seen In

Many market trends make it difficult for sponsors, CROs and other companies to excel at trial recruitment.

Regulatory Constraints

21.6K

Et has minim elitr intellegat. Mea aeterno eleifend antiopam ad, nam no suscipit quaerendum. Et has minim elitr intellegat. Mea aeterno eleifend antiopam ad, nam no suscipit quaerendum. Et has minim elitr intellegat.

Active Customers

Sponsors can't have a direct patient relationship. They must rely on third parties who can bridge the path to engaged patients at a cost they can afford during the drug development timeline.

  • Et has minim elitr intellegat.
  • Mae aeterno eleifend antiopam ad, nam no suscipit quarendum.
  • Et has minim elitr intellegat.
  • Mae aeterno eleifend antiopam ad, nam no suscipit quarendum.
  • Et has minim elitr intellegat.
  • Noisy Ad Channels

    21.6K

    Et has minim elitr intellegat. Mea aeterno eleifend antiopam ad, nam no suscipit quaerendum. Et has minim elitr intellegat. Mea aeterno eleifend antiopam ad, nam no suscipit quaerendum. Et has minim elitr intellegat.

    Active Customers

    Thousands of trials directed at the same patient through noisy digital channels make it extremely expensive to get a single brand impression let alone conversion.

  • Et has minim elitr intellegat.
  • Mae aeterno eleifend antiopam ad, nam no suscipit quarendum.
  • Et has minim elitr intellegat.
  • Mae aeterno eleifend antiopam ad, nam no suscipit quarendum.
  • Et has minim elitr intellegat.
  • Overtaxing Clinicians

    21.6K

    Et has minim elitr intellegat. Mea aeterno eleifend antiopam ad, nam no suscipit quaerendum. Et has minim elitr intellegat. Mea aeterno eleifend antiopam ad, nam no suscipit quaerendum. Et has minim elitr intellegat.

    Active Customers

    One trial site had just two dozen clinicians to recruit for 200 clinical trials while their primary focus needs to be treating their patients.

  • Et has minim elitr intellegat.
  • Mae aeterno eleifend antiopam ad, nam no suscipit quarendum.
  • Et has minim elitr intellegat.
  • Mae aeterno eleifend antiopam ad, nam no suscipit quarendum.
  • Et has minim elitr intellegat.
  • Trial Site Competition

    21.6K

    Et has minim elitr intellegat. Mea aeterno eleifend antiopam ad, nam no suscipit quaerendum. Et has minim elitr intellegat. Mea aeterno eleifend antiopam ad, nam no suscipit quaerendum. Et has minim elitr intellegat.

    Active Customers

    If a trial site has 20 - 200 trials in one health condition how is a single coordinator meant to recruit effectively?

  • Et has minim elitr intellegat.
  • Mae aeterno eleifend antiopam ad, nam no suscipit quarendum.
  • Et has minim elitr intellegat.
  • Mae aeterno eleifend antiopam ad, nam no suscipit quarendum.
  • Et has minim elitr intellegat.
  • High Staff Turnover

    21.6K

    Et has minim elitr intellegat. Mea aeterno eleifend antiopam ad, nam no suscipit quaerendum. Et has minim elitr intellegat. Mea aeterno eleifend antiopam ad, nam no suscipit quaerendum. Et has minim elitr intellegat.

    Active Customers

    Trial coordinators are the lifeline between patients and clinical trials but high turnover in these positions make it very difficult to recruit effectively.

  • Et has minim elitr intellegat.
  • Mae aeterno eleifend antiopam ad, nam no suscipit quarendum.
  • Et has minim elitr intellegat.
  • Mae aeterno eleifend antiopam ad, nam no suscipit quarendum.
  • Et has minim elitr intellegat.
  • 40% - 90% of Diagnoses

    21.6K

    Et has minim elitr intellegat. Mea aeterno eleifend antiopam ad, nam no suscipit quaerendum. Et has minim elitr intellegat. Mea aeterno eleifend antiopam ad, nam no suscipit quaerendum. Et has minim elitr intellegat.

    Active Customers

    Happen outside a clinical trial site. From decentralized partners to travel stipends, we can bring every trial to where a patient lives.

  • Et has minim elitr intellegat.
  • Mae aeterno eleifend antiopam ad, nam no suscipit quarendum.
  • Et has minim elitr intellegat.
  • Mae aeterno eleifend antiopam ad, nam no suscipit quarendum.
  • Et has minim elitr intellegat.
  • That's why MedAnswers is transforming how patients engage with research opportunities, and how researchers identify and enroll patients into their clinical trials.

    Patient-Centric

    25%

    Is not a buzzword, it's an unrelenting commitment that we FIRST serve patients generously and selflessly, to get the answers they need about their individual health condition. We all deserve better than Dr. Google and misinformation. We provide free answers to anonymous patients in private, mobile apps, and through the most used social media platforms by trusted, board-certified professionals.

    Data set

    Data-Driven

    25%

    Whether its fertility, neurology, COVID-19, Diabetes or more, we all have a health history. And it's up to us to collect data that is useful to an expert answering a patient question, and useful to matching patients algorithmically to the right solution, especially if that solution is an experimental treatment. Ask us how we can use genomics and prescription data to match patient data to your trial.

    Data set

    Life-Affirming

    25%

    Research breakthroughs can only happen when patients are willing to participate. These life-affirming diagnostic, treatment and therapeutic studies might be the key that eases their own suffering or unlocks the data to ease someone else's. What we like to avoid is patients filing out endless qualification forms. With MedAnswers, they complete one profile and match to the inclusion and exclusion criteria of all our trial partners. Coupled with their personal research risk and tolerance profile, we can find the right fit just about every time.

    Data set

    Engage Today. Recruit Tomorrow.

    Thank you! Your form has been successfully submitted.

    KENNETH A. GETZ, MBA

    Tufts Center for the Study of Drug Development (CSDD) and an expert on patient recruitment

    “The patient engagement movement is an effort to nurture a productive and meaningful partnership between the clinical trial industry and the public and patient communities,"